Le Lézard
Classified in: Health
Subject: v

Extendicare Announces July 2023 Dividend of C$0.04 per Share


MARKHAM, Ontario, July 17, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. ("Extendicare" or the "Company") (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the "Common Share") for the month of July 2023, which is payable on August 15, 2023 to shareholders of record at the close of business on July 31, 2023. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).

About Extendicare

Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. We are committed to delivering quality care throughout the health continuum to meet the needs of a growing seniors population. We operate or provide contract services to a network of 103 long-term care homes and retirement communities (53 owned/50 contract services), provide approximately 9.3 million hours of home health care services annually, and provide group purchasing services to third parties representing approximately 111,800 beds across Canada. Extendicare proudly employs approximately 18,000 qualified, highly trained and dedicated individuals who are passionate about providing high quality care and services to help people live better.

Forward-looking Statements

Information provided by Extendicare from time to time, including this release, contains or may contain forward-looking statements concerning anticipated future events, results, circumstances, economic performance or expectations with respect to Extendicare and its subsidiaries, including, without limitation, statements regarding its business operations, business strategy, growth strategy, results of operations and financial condition. Forward-looking statements can often be identified by the expressions "anticipate", "believe", "estimate", "expect", "intend", "objective", "plan", "project", "will", "may", "should" or other similar expressions or the negative thereof. These forward-looking statements reflect the Company's current expectations regarding future results, performance or achievements and are based upon information currently available to the Company and on assumptions that the Company believes are reasonable. The Company assumes no obligation to update or revise any forward-looking statement, except as required by applicable securities laws. These statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Company to differ materially from those expressed or implied in the statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on Extendicare's forward-looking statements. Further information can be found in the disclosure documents filed by Extendicare with the securities regulatory authorities, available at www.sedar.com and on Extendicare's website at www.extendicare.com.

Extendicare contact:

Jillian E. Fountain
Vice President, Investor Relations
T: (905) 470-5534
E: [email protected]
www.extendicare.com



These press releases may also interest you

at 16:25
The Memorial Health System (MHS) partnered with InVita Healthcare Technologies (InVita), Oracle Health, and Mississippi Organ Recovery Agency (MORA), the federally designated Organ Procurement Organization (OPO) serving most of the state of...

at 16:15
YS Biopharma Co., Ltd. ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and...

at 16:12
As a bill holding oil drillers accountable for health harms awaits a vote on the California Assembly Floor, Chevron reported spending $3 million lobbying in the first three months of the year to defeat that bill, AB 3155, the only bill it claims to...

at 16:10
Great Place to Work Institute and its senior care partner, Activated Insights, have once again honored Clearwater Living with certification as a Great Place to Work. This accolade marks the fifth time the company has participated in the survey and...

at 16:10
Envista Holdings Corporation ("Envista") today announced that the company will participate in the Stifel Jaws & Paws Conference on Wednesday, May 29, 2024 from 4:10 ? 4:40 pm ET in a Fireside Chat. There will be an audio-only recording link that can...

at 16:05
Neurocrine Biosciences, Inc.  today announced the publication of data from a post hoc analysis of the Phase 3 KINECT®-4 study of INGREZZA® (valbenazine) capsules in the Journal of Clinical Psychopharmacology. The analysis assessed long-term outcomes...



News published on and distributed by: